Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shandong Taihe Water Treatment Technologies Co., Ltd. (300801.SZ)
Zaozhuang, CN
Shandong Taihe Water Treatment Technologies Co., Ltd. focuses on the research, production, and sale of a wide array of chemicals designed for water treatment. Their product line encompasses various phosphonate-based solutions, such as antiscalants, corrosion inhibitors, and chelating agents, along with their corresponding salts. The company also offers polycarboxylic and biodegradable antiscalants and dispersants, biocides, algicides, and combined scale and corrosion inhibitors, including pretreatment filming agents. Additional specialized products include oxygen scavengers and reverse osmosis chemicals. These solutions are vital in numerous applications, ranging from industrial circulating cooling water systems in sectors like electricity, metallurgy, and petrochemicals, to reverse osmosis processes for seawater desalination and pure water generation. Furthermore, their chemicals are utilized in oil extraction, household products, textile and dyeing, paper and pulp manufacturing, ceramics, coatings, electronic cleaning, sugar production, aquaculture, and agriculture. Founded in 2006, the company is headquartered in Zaozhuang, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.80% | -9.44% | -10.99% | -14.60% | -10.34% | -2.39% | +70.91% | +52.55% | +44.69% | +10.85% | +10.85% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+19.1% ★ Q1'26: +11.7% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-38.6% Q1'26: +207.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-0.3% Q1'26: -4.9% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+3.5% Q1'26: +14.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%+4.1% ★ Q1'26: +16.3% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+1.4% Q1'26: -1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.19× ★ Q1'26: 0.34× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-25 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 116.3K | 0.39% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 22.7K | 0.46% |
| 3 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 58.7K | 0.28% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 39.8K | 0.29% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Lu Liang | Accounting Officer | — | male |
| Quanhua Liu | Deputy General Manager | — | male |
| Xiu Yan | Financial Director | — | female |
| Ya Yao | GM, Secretary & Director | — | female |
| Zhenzhen Ren | Deputy General Manager | — | female |
| Zhibo Ding | Deputy General Manager | — | male |
| Zhongfa Cheng | Chairman & Acting Secretary of the Board | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300801.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
